BIOLOGICAL · Unmapped registry intervention
ibalizumab (biologic/MAb) for SC Injection or placebo
Find medicine records ·
Find other trials using this name
Clinical trial
Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
NCT01292174
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
ibalizumab (biologic/MAb) for SC Injection or placebo
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
ibalizumab (biologic/MAb) for SC Injection or placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSafety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prevention of Infection With HIV-1unresolved
Interventions
Sponsors & collaborators
TaiMed Biologics Inc.lead sponsor
Aaron Diamond AIDS Research Centercollaborator
Bill and Melinda Gates Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01292174 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.